Dr Ian Nisbet Chief Operating Officer
Held in partnership with Harvard Stem Cell Institute, this virtual one-day investor and partner conference will explore stem cell therapeutics in the areas of regenerative medicine, oncology and emerging academic research. It will also showcase cutting-edge science, industry trends and the commercial potential of this innovative sector to an invited […]
Alan Trounson is ranked among the world’s most prominent scientists
In the following interview with ARMI Alan Trounson discusses the importance and challenges of translation
WELCOME to The Pipeline, the place where Cartherics team members share occasional news and views.
To get things rolling, Communications Adviser Leigh Dayton talked with cancer immunologist Ashleigh Unsworth, Cartherics’ latest recruit. Ashleigh joins the company from Peter MacCallum Cancer Centre where she conducted breast cancer research while […]
Our organising committee has been working relentlessly on this inaugural world conference having now assembled an excellent program of 40+ national and international opinion leaders. This conference is indeed something out of the ordinary.
Immunotherapy is on the cusp of revolutionising cancer treatment with some in the field even considering the potential of cure. With […]
Cartherics has been advised by the Hon Craig Laundy MP (Assistant Minister for Industry, Innovation and Science) that its application “Allogeneic Stem Cell Cancer Immunotherapies” in the 4th Cooperative Research Centres (CRC) Project Funding round has been successful.
Cartherics’ application was one of just 15 successful applications out of a total of 70 received in the 4th […]
Professor Jacques Miller a member of Cartherics’ Scientific Advisory Board wins “The Japan Prize Foundation says Walter and Eliza Hall Institute’s Prof Jacques Miller and Emory’s Prof Max Cooper have won the Japan Prize for Medical and Medicinal Science. A spokesperson for the Foundation told Biotech Daily that Prof Miller and Dr Cooper would share the […]
Immunotherapy : Professor Alan Trounson and Professor Richard Boyd started the future of cancer treatment at the Monash Health Translation Precinct.
Cartherics’ mission is the development of novel, immune cell therapy products for the treatment of cancer and endometriosis.
Stay informed about our latest news and developments
© Copyright 2022 – 2026| Cartherics Pty Ltd
